Abliva AB (publ) (NEVPF)

USD 0.04

(0.0%)

Revenue Summary of Abliva AB (publ)

  • Abliva AB (publ)'s latest annual revenue in 2023 was 137 Thousand SEK , up 356.71% from previous year.
  • Abliva AB (publ)'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Abliva AB (publ) reported a annual revenue of 2960.50 USD in annual revenue 2022, down -82.19% from previous year.
  • Abliva AB (publ) reported a annual revenue of 16.62 Thousand USD in annual revenue 2021, down -36.79% from previous year.
  • Abliva AB (publ) reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Abliva AB (publ) reported a quarterly revenue of 13.52 Thousand USD for 2023 FY, up 356.71% from previous quarter.

Annual Revenue Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Revenue of Abliva AB (publ) (2023 - 2007)

Year Revenue Revenue Growth
2023 137 Thousand SEK 356.71%
2022 2960.50 USD -82.19%
2021 16.62 Thousand USD -36.79%
2020 26.3 Thousand USD 83.74%
2019 14.31 Thousand USD 2438.12%
2018 563.96 SEK -82.9%
2017 3297.71 SEK 113.99%
2016 1541.07 SEK -99.48%
2015 296.77 Thousand SEK -95.85%
2014 7.15 Million SEK 34.06%
2013 5.33 Million SEK 0.0%
2012 - SEK -100.0%
2011 5.55 Million SEK 60.91%
2010 3.45 Million SEK -22.11%
2009 4.43 Million SEK 387.83%
2008 908.66 Thousand SEK 0.0%
2007 - SEK 0.0%

Peer Revenue Comparison of Abliva AB (publ)

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.131%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -677.481%
SQZ Biotechnologies Company 21.47 Million USD 99.362%
Evofem Biosciences, Inc. 18.21 Million USD 99.248%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.889%
Mesoblast Limited 5.9 Million USD 97.679%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.98%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 66.599%
Marizyme, Inc. 645.81 Thousand USD 78.786%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -78.476%
Intellipharmaceutics International Inc. 65.72 Thousand USD -108.435%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -246.677%
MultiCell Technologies, Inc. 49.32 USD -277677.778%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.724%
EV Biologics, Inc. 48.9 Thousand USD -180.164%
Q BioMed Inc. 284.35 Thousand USD 51.82%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.537%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.944%
Oncotelic Therapeutics, Inc. 70 Thousand USD -95.714%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -38.392%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -80.92%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 79.195%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Halberd Corporation 999.00 USD -13613.714%
Enzolytics Inc. 52.79 Thousand USD -159.489%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 89.993%
SYBLEU INC 11.69 Thousand USD -1071.341%
Nuo Therapeutics, Inc. 608.52 Thousand USD 77.487%
argenx SE 1.22 Billion USD 99.989%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 92.909%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 77.81%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.984%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.906%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 75.435%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 86.269%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.717%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 99.179%
ONE Bio Corp. 52.29 Million USD 99.738%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 42.087%
Regen BioPharma, Inc. 236.56 Thousand USD 42.087%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 2.312%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 71.081%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.241%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -953.846%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -246.537%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 95.886%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 97.944%
IntelGenx Technologies Corp. 1.03 Million USD 86.814%
Gelesis Holdings, Inc. 25.76 Million USD 99.468%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 81.854%